Related Experiment Video
Updated: Jun 14, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Functional availability of gamma-herpesvirus K-cyclin is regulated by cellular CDK6 and p16INK4a
Hidenori Yoshioka1, Kohji Noguchi, Kazuhiro Katayama
1Division of Chemotherapy, Faculty of Pharmacy, Keio University, 1-5-30 Shiba-koen, Minato-ku, Tokyo 105-8512, Japan.
Abstract:
Viral K-cyclin derived from Kaposi's sarcoma-associated herpesvirus is homologous with mammalian D-type cyclins. Here, we demonstrated the regulatory mechanisms for K-cyclin function and degradation in human embryonic kidney HEK293 and primary effusion lymphoma JSC-1 cell lines. Proteasome inhibitor MG132 treatment induced an accumulation of ubiquitinated K-cyclin in these cells, and co-expression of CDK6 prevented K-cyclin ubiquitination. Also K-cyclin mutants incompetent for CDK6-binding were destabilized by proteasome pathway. Furthermore, silencing of p16INK4a promoted K-cyclin-CDK6 complex formation and hence induced K-cyclin-associated kinase activity in HEK293 cells. These observations indicate that CDK6-bound K-cyclin is functionally stable but monomeric K-cyclin is targeted to ubiquitin-dependent degradation pathway in these cells. Our data suggest that the balance between CDK6 and p16INK4a regulates the availability of functional K-cyclin in human cells.
Insights
Viral K-cyclin stability is regulated by CDK6 binding and p16INK4a. CDK6 binding stabilizes K-cyclin, while its absence targets it for proteasomal degradation, impacting human cell function.
Area of Science:
- Molecular Biology
- Virology
- Cell Biology
Background:
- Kaposi's sarcoma-associated herpesvirus (KSHV) encodes viral K-cyclin, homologous to mammalian D-type cyclins.
- Understanding K-cyclin's regulatory mechanisms is crucial for comprehending viral pathogenesis and host cell cycle control.
Purpose of the Study:
- To elucidate the regulatory mechanisms governing K-cyclin function and degradation in human cells.
- To investigate the roles of CDK6 and p16INK4a in K-cyclin stability and activity.
Main Methods:
- Utilized human embryonic kidney (HEK293) and primary effusion lymphoma (JSC-1) cell lines.
- Employed proteasome inhibitor MG132 to assess K-cyclin ubiquitination and degradation.
- Investigated the effects of CDK6 co-expression and p16INK4a silencing on K-cyclin stability and complex formation.
Main Results:
- Proteasome inhibition (MG132) led to K-cyclin ubiquitination.
- CDK6 co-expression prevented K-cyclin ubiquitination, stabilizing the protein.
- K-cyclin mutants unable to bind CDK6 were degraded via the proteasome.
- p16INK4a silencing enhanced K-cyclin-CDK6 complex formation and kinase activity.
Conclusions:
- CDK6-bound K-cyclin is functionally stable, whereas monomeric K-cyclin undergoes ubiquitin-dependent degradation.
- The balance between CDK6 and p16INK4a critically regulates the availability of functional K-cyclin in human cells.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Positive Regulator Molecules
Negative Regulator Molecules
Anaphase Promoting Complex

